Given that p53 and Tum-5 proteins can inhibit tumor growth through different mechanisms, we envisaged that the combination of the ability of p53 protein to directly induce apoptosis in tumor cells and the anti-angiogenic function of Tum-5 could be a potential gene therapy for cancer treatment. This evidence concerns the gene TP53 and cancer.